ENTX vs IBO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
IBO Captures Institutional Edge (3โ1 Pillars ยท 5โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Impact BioMedical, Inc. (IBO) driven by superior Valuation, Growth & Margin, Momentum & Technical while ENTX counters with relative strength in Options & Structure. Fundamentally, ENTX trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus IBO at N/M Forward P/E and -12621.0% operating margin (+16.7% YoY). In options structure, ENTX sits in CONSOLIDATION (32nd %ile IV; Dealer Gamma Walls on Pro) against IBO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ENTX Revenue | IBO Revenue | ENTX Op. Margin | IBO Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2020 | $0M | N/A | -3059.7% | N/A | ENTX |
| FY2021 | $0M | N/A | -2139.6% | N/A | ENTX |
| FY2022 | $0M | $0M | -9714.2% | -6808.0% | IBO |
| FY2024 | $0M | N/A | -5295.6% | N/A | ENTX |
| FY2025 | $0M | $0M | -27450.0% | -13381.2% | IBO |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ENTX | IBO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $541.6M | $44.4M | Larger Scale | ENTX |
| Trailing P/E Ratio Valuation | N/M | 0.4x | Lower Multiple | IBO |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -100.0% | +16.7% | Higher Growth | IBO |
| Operating Margin (TTM) Profitability | 0.0% | -12621.0% | Higher Margin | ENTX |
| Net Profit Margin Profitability | 0.0% | 4247.4% | Higher Margin | IBO |
| Return on Equity (ROE) Capital Efficiency | -20.3% | 71.2% | Higher ROE | IBO |
| 52-Week Range Position Momentum | 64% ($1โ$4) | 67% ($0โ$7) | Stronger Trend | IBO |
| Beta / 30D Volatility Risk Regime | 1.07ฮฒ ยท 46% Vol | -6.72ฮฒ ยท 120% Vol | Lower Realized Risk | ENTX |
| Unified Institutional Score Composite Signal | 48.1 / 100 (HOLD) | 36.8 / 100 (SELL) | Higher Composite | ENTX |